Clinical trial
The Effects of Per3, Clock Polymorphism on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy.
NCT01887925 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Per3, Clock Polymorphism on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy.
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- May 31, 2015
- Enrollment
- 224 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.